Potent THC 'dabs' pose problems for some users

November 29, 2022

Potent THC 'dabs' pose problems for some users

Washington state’s pioneering move to legalize recreational cannabis has resulted not only in widely available leaf versions of the drug, but also high-potency “dabs” and vapes whose levels of THC, the psychoactive part of cannabis, are well above that of a rolled joint.

“Since legalization, we’re getting plants (with) between 10 and 20% THC. With legalization also came this drive of the industry to develop new products, and these products have way, way, way higher THC concentration,” says Beatriz Carlini, an acting associate professor at the Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, University of Washington School of Medicine.

She is lead author of a paper submitted recently to state legislators about options to regulate the sale of the high-potency products with 60% to 90% THC, which have led inexperienced users to end up in hospital emergency rooms with paranoia and panic attacks, she says. Continued use of these products can lead to the development of a permanent psychotic disorder, she added.

Carlini explores the emerging issue in our blog post.

Download video soundbites of Carlini discussing high-potency THC products.

Credit: 
Getty Images
Category: 
YouTube

Terms of appropriate usage of file downloads

  • News reporters and news organizations may freely republish and distribute videos, still images and audio files produced by UW Medicine and the University of Washington School of Medicine.
  • Works must be attributed/credited appropriately (for example, “UW Medicine” – as denoted in the file) and must not be used for commercial purposes.
  • These visual and audio files may not be used to exploit or misrepresent UW Medicine or the University of Washington.
  • UW Medicine often licenses still images from Thinkstock but cannot grant republishing rights. You may not republish single image files credited to Thinkstock.
  • Logos of UW Medicine and University of Washington Health Sciences schools may not be republished without explicit permission. Contact us by phone or email: 206.543.3620 or mediarelations@uw.edu